Raltegravir potassium
Raltegravir Potassium
Raltegravir potassium (pronunciation: ral-TEG-ra-vir po-TAS-ee-um) is an antiretroviral medication used in the treatment of HIV (Human Immunodeficiency Virus) infection. It belongs to a class of drugs known as integrase inhibitors.
Etymology
The name "Raltegravir" is derived from the words "integrase" and "viral", referring to the drug's mechanism of action. The "potassium" part of the name indicates the presence of a potassium salt in the drug formulation.
Mechanism of Action
Raltegravir potassium works by inhibiting the action of an enzyme called integrase, which is essential for the replication of the HIV virus. By blocking this enzyme, the drug prevents the virus from multiplying in the body.
Usage
Raltegravir potassium is used in combination with other antiretroviral drugs to treat HIV infection. It is not a cure for HIV or AIDS, but it can help to control the infection and decrease the risk of complications.
Side Effects
Common side effects of raltegravir potassium include nausea, headache, and fatigue. Serious side effects may include severe skin reactions, liver problems, and changes in body fat distribution.
Related Terms
External links
- Medical encyclopedia article on Raltegravir potassium
- Wikipedia's article - Raltegravir potassium
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski